Serine phosphorylation regulates the P-type potassium pump KdpFABC

  1. Marie E Sweet
  2. Xihui Zhang
  3. Hediye Erdjument-Bromage
  4. Vikas Dubey
  5. Himanshu Khandelia
  6. Thomas A Neubert
  7. Bjorn P Pedersen
  8. David L Stokes  Is a corresponding author
  1. NYU School of Medicine, United States
  2. University of Southern Denmark, Denmark
  3. Aarhus University, Denmark

Abstract

KdpFABC is an ATP-dependent K+ pump that ensures bacterial survival in K+-deficient environments. Whereas transcriptional activation of kdpFABC expression is well studied, a mechanism for down regulation when K+ levels are restored has not been described. Here we show that KdpFABC is inhibited when cells return to a K+-rich environment. The mechanism of inhibition involves phosphorylation of Ser162 on KdpB, which can be reversed in vitro by treatment with serine phosphatase. Mutating Ser162 to Alanine produces constitutive activity, whereas the phosphomimetic Ser162Asp mutation inactivates the pump. Analyses of the transport cycle show that serine phosphorylation abolishes the K+-dependence of ATP hydrolysis and blocks the catalytic cycle after formation of the aspartyl phosphate intermediate (E1~P). This regulatory mechanism is unique amongst P-type pumps and this study furthers our understanding of how bacteria control potassium homeostasis to maintain cell volume and osmotic potential.

Data availability

Raw mass spectrometry files have been deposited to the MassIVE database under accession code MSV000084906

The following data sets were generated

Article and author information

Author details

  1. Marie E Sweet

    Skirball Institute, NYU School of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  2. Xihui Zhang

    Skirball Institute, NYU School of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  3. Hediye Erdjument-Bromage

    Skirball Institute, NYU School of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Vikas Dubey

    University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  5. Himanshu Khandelia

    University of Southern Denmark, Odense, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  6. Thomas A Neubert

    Skirball Institute, NYU School of Medicine, New York, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Bjorn P Pedersen

    Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark
    Competing interests
    The authors declare that no competing interests exist.
  8. David L Stokes

    Skirball Institute, NYU School of Medicine, New York, United States
    For correspondence
    stokes@nyu.edu
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5455-8163

Funding

National Institutes of Health (R01 GM108043)

  • David L Stokes

National Institutes of Health (S10 RR027990)

  • Thomas A Neubert

European Research Council (637372)

  • Bjorn P Pedersen

Independent Research Fund Denmark (DFF-8021-00161)

  • Bjorn P Pedersen

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Sweet et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,304
    views
  • 171
    downloads
  • 18
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Marie E Sweet
  2. Xihui Zhang
  3. Hediye Erdjument-Bromage
  4. Vikas Dubey
  5. Himanshu Khandelia
  6. Thomas A Neubert
  7. Bjorn P Pedersen
  8. David L Stokes
(2020)
Serine phosphorylation regulates the P-type potassium pump KdpFABC
eLife 9:e55480.
https://doi.org/10.7554/eLife.55480

Share this article

https://doi.org/10.7554/eLife.55480

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Katherine A Senn, Karli A Lipinski ... Aaron A Hoskins
    Research Article

    Pre-mRNA splicing is catalyzed in two steps: 5ʹ splice site (SS) cleavage and exon ligation. A number of proteins transiently associate with spliceosomes to specifically impact these steps (first and second step factors). We recently identified Fyv6 (FAM192A in humans) as a second step factor in Saccharomyces cerevisiae; however, we did not determine how widespread Fyv6’s impact is on the transcriptome. To answer this question, we have used RNA sequencing (RNA-seq) to analyze changes in splicing. These results show that loss of Fyv6 results in activation of non-consensus, branch point (BP) proximal 3ʹ SS transcriptome-wide. To identify the molecular basis of these observations, we determined a high-resolution cryo-electron microscopy (cryo-EM) structure of a yeast product complex spliceosome containing Fyv6 at 2.3 Å. The structure reveals that Fyv6 is the only second step factor that contacts the Prp22 ATPase and that Fyv6 binding is mutually exclusive with that of the first step factor Yju2. We then use this structure to dissect Fyv6 functional domains and interpret results of a genetic screen for fyv6Δ suppressor mutations. The combined transcriptomic, structural, and genetic studies allow us to propose a model in which Yju2/Fyv6 exchange facilitates exon ligation and Fyv6 promotes usage of consensus, BP distal 3ʹ SS.

    1. Biochemistry and Chemical Biology
    2. Neuroscience
    Eyal Paz, Sahil Jain ... Abdussalam Azem
    Research Article

    TIMM50, an essential TIM23 complex subunit, is suggested to facilitate the import of ~60% of the mitochondrial proteome. In this study, we characterized a TIMM50 disease-causing mutation in human fibroblasts and noted significant decreases in TIM23 core protein levels (TIMM50, TIMM17A/B, and TIMM23). Strikingly, TIMM50 deficiency had no impact on the steady-state levels of most of its putative substrates, suggesting that even low levels of a functional TIM23 complex are sufficient to maintain the majority of TIM23 complex-dependent mitochondrial proteome. As TIMM50 mutations have been linked to severe neurological phenotypes, we aimed to characterize TIMM50 defects in manipulated mammalian neurons. TIMM50 knockdown in mouse neurons had a minor effect on the steady state level of most of the mitochondrial proteome, supporting the results observed in patient fibroblasts. Amongst the few affected TIM23 substrates, a decrease in the steady state level of components of the intricate oxidative phosphorylation and mitochondrial ribosome complexes was evident. This led to declined respiration rates in fibroblasts and neurons, reduced cellular ATP levels, and defective mitochondrial trafficking in neuronal processes, possibly contributing to the developmental defects observed in patients with TIMM50 disease. Finally, increased electrical activity was observed in TIMM50 deficient mice neuronal cells, which correlated with reduced levels of KCNJ10 and KCNA2 plasma membrane potassium channels, likely underlying the patients’ epileptic phenotype.